RN7SK pseudogene 245 (RN7SKP245)

RN7SK pseudogene 245 (RN7SKP245) is classified as a **pseudogene**, meaning it is a genomic DNA sequence similar to the functional RN7SK gene but is considered nonfunctional and does not encode a protein or active RNA product[3]. Pseudogenes arise from gene duplication or retrotransposition and typically lack the ability to produce a functional molecule, due to accumulated mutations or lack of necessary regulatory elements. While the functional RN7SK gene encodes the 7SK small nuclear RNA, a regulator of transcription elongation by RNA polymerase II[1][5][6], RN7SKP245 is not known to play any biological or pathological role, nor to interact with drugs or serve as a biomarker. This entry refers to a pseudogene, not an active molecular target or receptor, and therefore does not fulfill the usual criteria for therapeutic targeting, biological function, or disease relevance. Its inclusion in target lists is likely incorrect for most research, clinical, or pharmacological purposes[3]. There is no evidence that RN7SKP245 is anything other than a pseudogene, and it should *not* be treated as a drug target.

Other names

RN7SKP245RN7SK Pseudogene 245